High doses of cholesterol-lowering drugs called statins may protect patients from heart attack, but a new analysis of five previous clinical trials finds that they may also increase patients’ risk of ...

Statins lower cholesterol levels, reduce the risk of heart attack and stroke, and improve overall heart health. In the late 1970s, researchers found that a substance called mevastatin, isolated from a ...

Medically reviewed by Anisha Shah, MD Key Takeaways Crestor and Lipitor are statins that help lower cholesterol and ...

If your doctor suggested you take a statin but you’re not following that advice, you’re not the only one who isn’t filling that prescription. Many people who are candidates for these popular ...

Add Yahoo as a preferred source to see more of our stories on Google. Nice has set specific cholesterol targets for those who have already suffered a heart attack or stroke. Two million people will be ...

There is no one-size-fits-all safest statin. The best choice depends on the side effects a person experiences, their co-occurring conditions, and other medications they take. If a person cannot ...

I have seen 2 studies (the Treating to New Targets [TNT] trial and the Study To evaluate the Effect of Rosuvastatin On Intravascular ultrasound-Derived [ASTEROID] coronary atheroma burden trial) in ...

Statin dosage does not seem to affect recurrence. * THE QUESTION It's clear that high doses of statins will lower cholesterol and help prevent heart disease. But once someone has had a heart attack, ...

Please provide your email address to receive an email when new articles are posted on . High-intensity statin therapy may increase bleeding risk after minor stroke. Statin dose, moderate or high, did ...

As we reach a certain age, many of us begin reaching for our pill bottles, as well as a nice glass of red. With more than 10 million people in England now eligible for statins, the cholesterol ...

A new breakthrough could change how high cholesterol is treated, offering a powerful alternative to traditional drugs. Researchers have developed tiny DNA-based molecules that shut down PCSK9—a key ...